Real Assets

Real Assets

We build future energy systems and resilient infrastructure, backing emerging opportunities in technology, land and water.

Latest news

News

Foresight backs IT services provider VS Group

Latest news

News

Foresight backs IT services provider VS Group

Featured insight

Insights

One for the money, two for the show: how repeated energy shocks reshape global economies.

Skip to main content
News

Foresight invests in Envoke

A Leeds-based lab simulation software company targeting Asia‑Pacific growth

Foresight Group ("Foresight"), a leading private equity and real assets manager, has invested in Envoke, a UK-based lab simulation software company, following a £1.6m funding round completed alongside other investors.

Founded in 2019 and based in Leeds, Envoke develops software that enables remote training, diagnostics and support for complex laboratory equipment. Its platform creates virtual replicas of individual machines and uses interactive simulations to train laboratory staff, support troubleshooting and reduce the need for on‑site engineering callouts.

Envoke’s technology is already used by major laboratory equipment manufacturers and healthcare providers, including organisations in the US and the UK. By enabling remote troubleshooting and improved operator training, the platform has been shown to reduce service callouts by 15–20%, helping manufacturers lower servicing costs while keeping equipment operational for longer. The system also captures real time data on user competence, providing insights into training gaps and their impact on laboratory performance.

The company has recently secured a number of new international clients and is now targeting further global adoption as demand for virtual training and maintenance solutions continues to grow. Envoke expects to exceed £1m in annual recurring revenue within the next 12 months and plans to create three to five new UK jobs over the year ahead.

Line Gauteplass, Senior Investment Manager at Foresight, said: “Envoke has developed a compelling platform that addresses real operational challenges for both laboratory equipment manufacturers and healthcare providers. The business has already demonstrated strong traction with leading global customers, and we see significant potential as it expands internationally, particularly across Asia‑Pacific. We are pleased to support Stuart and the team as they scale the business and build on this next phase of growth.”

Notes to editors

Related News & Insights

You have viewed 0 of 0